|
Press Releases |
|
 |
|
Saturday, July 27, 2013 |
|
Singapore Scientists Discover New Drug Targets for Aggressive Breast Cancer |
Scientists at A*STAR's Genome Institute of Singapore (GIS) led in a study that has identified genes that are potential targets for therapeutic drugs against aggressive breast cancer. These findings were reported in the July 2013 issue of PNAS. more info >> |
|
Tuesday, July 2, 2013 |
|
Genome Institute of Singapore Scientists Discover Molecular Communication Network in Human Stem Cells |
Scientists at A*STAR's Genome Institute of Singapore (GIS) and the Max Planck Institute for Molecular Genetics (MPIMG) in Berlin (Germany) have discovered a molecular network in human embryonic stem cells (hESCs) that integrates cell communication signals to keep the cell in its stem cell state. These findings were reported in the June 2013 issue of Molecular Cell. more info >> |
|
Friday, May 17, 2013 |
|
A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing |
Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their H1N1 influenza vaccine candidate based on Cytos' proprietary bacteriophage Qbeta virus-like particle (VLP) technology. more info >> |
|
Thursday, April 25, 2013 |
|
A*STAR and Veredus Laboratories Create Market's First Lab-on-Chip for the Detection of Multiple Tropical Infectious Diseases |
The Agency for Science, Technology and Research (A*STAR) and Veredus Laboratories, a leading supplier of innovative molecular diagnostic tools, announced the launch of VereTrop(TM), the first biochip in the molecular diagnostics market that can identify 13 different major tropical diseases from a single blood sample. more info >> |
|
Monday, April 22, 2013 |
|
Understanding Abnormal Proteins in Degenerative Diseases |
Now, a new class of ultrasmall peptides developed by the Institute of Bioengineering and Nanotechnology (IBN) offers scientists a platform for understanding abnormal proteins, providing them with the insights required to design more effective treatments for degenerative diseases such as Alzheimer's, diabetes and cancer. more info >> |
|
Thursday, April 18, 2013 |
|
Singapore Scientist Wins Coveted Chen New Investigator Award 2013 |
Dr Patrick Tan from A*STAR's Genome Institute of Singapore (GIS) has received the 2013 Chen New Investigator Award from the international Human Genome Organisation (HUGO). more info >> |
|
A*STAR Scientists Decipher Genome Code of a Living Fossil |
An enigmatic prehistoric fish has brought scientists at A*STAR's Institute of Molecular and Cell Biology (IMCB) together with researchers from all over the world to crack its genomic code. Findings from the study are providing new insights into the evolutionary history of the African coelacanth and possible clues as to how aquatic creatures transitioned to life on land. more info >> |
|
Friday, April 5, 2013 |
|
A*STAR Scientist Alex Matter Awarded Prestigious Szent-Gyorgyi Prize For Progress In Cancer Research |
Professor Alex Matter, Chief Executive Officer of A*STAR's Experimental Therapeutics Centre (ETC), has been awarded the 8th Annual Szent-Gyorgyi Prize for Progress in Cancer Research by the National Foundation for Cancer Research (NFCR) for his contributions to the development of the first drug specifically targeting a molecular lesion in cancer. more info >> |
|
Tuesday, April 2, 2013 |
|
New Singapore Plastic Film is the Future of 3D On-the-go |
This latest innovation from TP and IMRE is the first ever glasses-free 3D accessory that can display content in both portrait and landscape mode, and measures less than 0.1 mm in thickness. more info >> |
|
Tuesday, March 19, 2013 |
|
A*STAR's Antibody Technology Bags Regional Award |
VeriStem Technologies, a spin-off from A*STAR's Bioprocessing Technology Institute (BTI), has been awarded the Biospectrum Asia-Pacific Emerging Companies of the Year Award 2013. more info >> |
|
|
|
|
|
|
|
|
 |
Latest Press Releases |
 |
Queensland's First Nations businesses forge global trade links
Aug 26, 2025 22:39 HKT/SGT
|
|
|
Resilient Interim Results, Essex Bio-Technology Drives Growth and Innovation
Aug 26, 2025 20:00 HKT/SGT
|
|
|
Kincora Copper: Positive Drilling Results at Two Northern Junee-Narromine Belt Projects
Aug 26, 2025 19:09 HKT/SGT
|
|
|
31 Concept and Bestcomp Group Form Strategic Partnership to Elevate AI-Driven Network Intelligence Across Eurasia
Aug 26, 2025 18:30 HKT/SGT
|
|
|
Focus Graphite Achieves First Aerospace Validation with Lac Knife Graphite in a Successful Hypersonic Rocket Launch
Aug 26, 2025 17:09 HKT/SGT
|
|
|
Shuangdeng Group Listed on the Main Board of the Hong Kong Stock Exchange
Aug 26, 2025 16:39 HKT/SGT
|
|
|
Nissin Foods Announces 2025 Interim Results
Aug 26, 2025 14:15 HKT/SGT
|
|
|
VCREDIT 2025 Interim Results: Driving High-Quality Growth through a Solidified Digital Financial Ecosystem and Strategic Advancement
Aug 26, 2025 13:39 HKT/SGT
|
|
|
TANAKA to Showcase Advanced Semiconductor Materials in its Inaugural Participation at SEMICON India 2025
Aug 26, 2025 13:30 JST
|
|
|
Honda to Hold Official e-Motorsports Event, "Honda Racing eMS 2025"
Aug 26, 2025 13:17 JST
|
|
|
Mitsubishi Corporation Invests in Fullerton Health
Aug 26, 2025 12:54 JST
|
|
|
Austria and Germany to become the first markets in the European Union (EU) to launch LEQEMBI(R) (lecanemab)
Aug 25, 2025 19:30 JST
|
|
|
Shibaura Institute of Technology, Waseda University and Fujitsu develop quantum computer-based robot posture optimization
Aug 25, 2025 18:22 JST
|
|
|
Dida Inc. (02559.HK) Announced 2025 Interim Results, RMB 135.8 Million Adjusted Net Profit
Aug 25, 2025 17:03 HKT/SGT
|
|
|
NEC technology predicts sudden traffic congestion in real time using optical fiber cables
Aug 25, 2025 17:30 JST
|
|
|
|
More Press release >> |
|
|
 |
 |
 |
|
|